CLOV vs JCI · rev $1.37B vs P/E 44, rev $23.60B
Clover Health Investments Corp (CLOV) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
CLOV currently screens at market cap $1.55B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the CLOV and JCI stock pages for the full models.
Not investment advice.